Clinical Trial

Deciphering the Molecular Traits of Non-canonical Responders to Advance Personalized Therapy in Gastric Cancer

Name: Deciphering the Molecular Traits of Non-canonical Responders to Advance Personalized Therapy in Gastric Cancer — clinical trial record (NCT06877910)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting

View on ClinicalTrials.gov →

Summary

Retrospective-prospective observational study in which a novel whole-exome sequencing (WES) approach will be used in association with whole-transcriptome sequencing (WTS) to analyze two independent and equally sized cohorts of patients with mGC.

Trial Details

NCT Number	NCT06877910
Lead Sponsor	Regina Elena Cancer Institute
Conditions	Metastatic Gastric Cancer
Enrollment	220 participants
Start Date	2021-01-10
Primary Completion	2023-06-20 (estimated)
Study Completion	2026-01-10 (estimated)
Updated on ClinicalTrials.gov	2025-03-14